Wong Vivien 4
4 · Cyclo Therapeutics, Inc. · Filed Mar 3, 2025
Insider Transaction Report
Form 4
Wong Vivien
Director
Transactions
- Award
Common Stock
2025-02-27+25,140→ 64,853 total
Footnotes (1)
- [F1]Represents the grant of fully-vested shares of common stock that the Reporting Person elected to receive in lieu of cash compensation under the issuer's non-employee director compensation policy. Grant reflects director compensation for the fourth quarter of 2024 and from January 1, 2025 through March 25, 2025. The number of shares received in lieu of cash was calculated based on the closing price of $0.77 per share of common stock on February 26, 2025.